Health Dose: A Weekly Update on Washington, D.C. Legislative and Regulatory Developments Affecting the Health Sector
The health sector continues to face a host of legislative and regulatory challenges in Washington, D.C., with several important developments taking place this week. The FAA Reauthorization, the Congressional Budget Office Data Sharing Act, the Senate Committee on Finance’s discussion draft on drug shortages, and the House Ways and Means Committee’s preparation to mark up legislation to extend telehealth waivers are among the topics that stakeholders should be aware of.
In addition to these developments, FDA officials will appear before the Energy and Commerce Subcommittee, and there will be House and Senate hearings on administrative and regulatory burdens in healthcare. Last week saw hearings on cybersecurity threats, Medicaid and long-term services and supports, maternal mortality, workforce diversity, Medicare and Social Security Trustees’ annual reports, cost-sharing FAQs released by HHS/DOL/Treasury Departments.
HHS has also released draft guidance for the second cycle of the Medicare Drug Price Negotiation Program while FDA has released Laboratory Developed Test Final Rule. The DACA health coverage rule has been finalized as well as MACPAC appointments news are ongoing. These are just some of the many issues currently shaping healthcare policy in Washington, D.C., so it is important for stakeholders to stay informed about these developments by reading our full Health Dose report.